Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers in unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (atezo-bev).

Authors :: Wu, Linda
Fulgenzi, Claudia A.M.
D'Alessio, Antonio
Chon, Hong Jae
Kudo, Masatoshi
Schönlein, Martin
Felden, Johann von
Wietharn, Brooke
Phen, Samuel
Scheiner, Bernhard
Balcar, Lorenz
Huang, Yi-Hsiang
Pressiani, Tiziana
Masi, Gianluca
Naqash, Abdul Rafeh
Bettinger, Dominik
Vogel, Arndt
Galle, Peter R
Gaillard, Vince
Ang, Celina
Source :: Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p504-504, 1p
Publication Year :: 2023

Full Text Access

Tools